Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents

ÇELİKER ATABERK H. , Kazokoglu H., Direskeneli H.

BMC OPHTHALMOLOGY, cilt.18, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background: To report the switch rate of conventional immunosuppressive (CIS) therapies to the biological agents (BA) in patients with refractory Behcet's uveitis (BU).